These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 31663375)

  • 1. Interleukins and miRNAs intervene in the early stages of diabetic kidney disease in Type 2 diabetes mellitus patients.
    Petrica L; Milas O; Vlad M; Vlad A; Gadalean F; Dumitrascu V; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Jianu DC; Matusz P; Pusztai AM; Cretu O; Radu D; Secara A; Simulescu A; Stefan M; Popescu R; Vlad D
    Biomark Med; 2019 Dec; 13(18):1577-1588. PubMed ID: 31663375
    [No Abstract]   [Full Text] [Related]  

  • 2. Long noncoding RNAs may impact podocytes and proximal tubule function through modulating miRNAs expression in Early Diabetic Kidney Disease of Type 2 Diabetes Mellitus patients.
    Petrica L; Hogea E; Gadalean F; Vlad A; Vlad M; Dumitrascu V; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Jianu DC; Matusz P; Pusztai AM; Motoc A; Cretu OM; Radu D; Milas O; Golea-Secara A; Simulescu A; Mogos-Stefan M; Patruica M; Balint L; Ienciu S; Vlad D; Popescu R
    Int J Med Sci; 2021; 18(10):2093-2101. PubMed ID: 33859515
    [No Abstract]   [Full Text] [Related]  

  • 3. MiRNA Expression is Associated with Clinical Variables Related to Vascular Remodeling in the Kidney and the Brain in Type 2 Diabetes Mellitus Patients.
    Petrica L; Pusztai AM; Vlad M; Vlad A; Gadalean F; Dumitrascu V; Vlad D; Velciov S; Gluhovschi C; Bob F; Ursoniu S; Petrica M; Matusz P; Cretu O; Radu D; Milas O; Secara A; Simulescu A; Popescu R; Jianu DC
    Endocr Res; 2020; 45(2):119-130. PubMed ID: 31724439
    [No Abstract]   [Full Text] [Related]  

  • 4. Deregulated profiles of urinary microRNAs may explain podocyte injury and proximal tubule dysfunction in normoalbuminuric patients with type 2 diabetes mellitus.
    Milas O; Gadalean F; Vlad A; Dumitrascu V; Gluhovschi C; Gluhovschi G; Velciov S; Popescu R; Bob F; Matusz P; Pusztai AM; Cretu OM; Secara A; Simulescu A; Ursoniu S; Vlad D; Petrica L
    J Investig Med; 2018 Apr; 66(4):747-754. PubMed ID: 29279420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Serum microRNAs in Patients with Diabetic Kidney Disease: A Nested Case-Controlled Study and Bioinformatics Analysis.
    Regmi A; Liu G; Zhong X; Hu S; Ma R; Gou L; Zafar MI; Chen L
    Med Sci Monit; 2019 Mar; 25():1699-1708. PubMed ID: 30835718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical verification of a novel urinary microRNA panal: 133b, -342 and -30 as biomarkers for diabetic nephropathy identified by bioinformatics analysis.
    Eissa S; Matboli M; Bekhet MM
    Biomed Pharmacother; 2016 Oct; 83():92-99. PubMed ID: 27470555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pro-inflammatory cytokines are associated with podocyte damage and proximal tubular dysfunction in the early stage of diabetic kidney disease in type 2 diabetes mellitus patients.
    Milas O; Gadalean F; Vlad A; Dumitrascu V; Velciov S; Gluhovschi C; Bob F; Popescu R; Ursoniu S; Jianu DC; Matusz P; Pusztai AM; Secara A; Simulescu A; Stefan M; Patruica M; Petrica F; Vlad D; Petrica L
    J Diabetes Complications; 2020 Feb; 34(2):107479. PubMed ID: 31806428
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High Serum Uric Acid Is Associated with Tubular Damage and Kidney Inflammation in Patients with Type 2 Diabetes.
    Guarda NS; Bollick YS; de Carvalho JAM; Premaor MO; Comim FV; Moresco RN
    Dis Markers; 2019; 2019():6025804. PubMed ID: 31110596
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association Between Estimated Glomerular Filtration Rate and Microvascular Complications in Type II Diabetes Mellitus Patients: A 1-Year Cross-Sectional Study.
    Babaliche P; Nadpara RA; Maldar A
    J Natl Med Assoc; 2019 Feb; 111(1):83-87. PubMed ID: 30032867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
    Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
    Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary Exosomal miRNA Signature in Type II Diabetic Nephropathy Patients.
    Delić D; Eisele C; Schmid R; Baum P; Wiech F; Gerl M; Zimdahl H; Pullen SS; Urquhart R
    PLoS One; 2016; 11(3):e0150154. PubMed ID: 26930277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Expression of Tristetraprolin and Its Relationship with Urinary Proteins in Patients with Diabetic Nephropathy.
    Liu F; Guo J; Zhang Q; Liu D; Wen L; Yang Y; Yang L; Liu Z
    PLoS One; 2015; 10(10):e0141471. PubMed ID: 26517838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary Exosomal MicroRNA Profiling in Incipient Type 2 Diabetic Kidney Disease.
    Xie Y; Jia Y; Cuihua X; Hu F; Xue M; Xue Y
    J Diabetes Res; 2017; 2017():6978984. PubMed ID: 29038788
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR302a-3p May Modulate Renal Epithelial-Mesenchymal Transition in Diabetic Kidney Disease by Targeting ZEB1.
    Tang WB; Zheng L; Yan R; Yang J; Ning J; Peng L; Zhou Q; Chen L
    Nephron; 2018; 138(3):231-242. PubMed ID: 29227974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum interleukin-18 levels are associated with nephropathy and atherosclerosis in Japanese patients with type 2 diabetes.
    Nakamura A; Shikata K; Hiramatsu M; Nakatou T; Kitamura T; Wada J; Itoshima T; Makino H
    Diabetes Care; 2005 Dec; 28(12):2890-5. PubMed ID: 16306550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive impact of elevated serum level of IL-18 for early renal dysfunction in type 2 diabetes: an observational follow-up study.
    Araki S; Haneda M; Koya D; Sugimoto T; Isshiki K; Chin-Kanasaki M; Uzu T; Kashiwagi A
    Diabetologia; 2007 Apr; 50(4):867-73. PubMed ID: 17225121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is IL-33 useful to detect early stage of renal failure?
    Caner S; Usluoğulları CA; Balkan F; Büyükcam F; Kaya C; Saçıkara M; Koca C; Ersoy R; Çakır B
    Ren Fail; 2014 Feb; 36(1):78-80. PubMed ID: 24028569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum and Urinary Progranulin in Diabetic Kidney Disease.
    Nicoletto BB; Krolikowski TC; Crispim D; Canani LH
    PLoS One; 2016; 11(10):e0165177. PubMed ID: 27776152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrant cytokines/chemokines production correlate with proteinuria in patients with overt diabetic nephropathy.
    Wu CC; Chen JS; Lu KC; Chen CC; Lin SH; Chu P; Sytwu HK; Lin YF
    Clin Chim Acta; 2010 May; 411(9-10):700-4. PubMed ID: 20138168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc alpha 2 glycoprotein as an early biomarker of diabetic nephropathy in patients with type 2 diabetes mellitus.
    Elsheikh M; Elhefnawy KA; Emad G; Ismail M; Borai M
    J Bras Nefrol; 2019; 41(4):509-517. PubMed ID: 30897192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.